SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

15.88p
   
  • Change Today:
    -0.38p
  • 52 Week High: 19.50p
  • 52 Week Low: 7.25p
  • Currency: UK Pounds
  • Shares Issued: 228.44m
  • Volume: 615,738
  • Market Cap: £36.26m
  • Beta: 1.22

SBTX Overview

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

Key Personnel

CEO: Stuart Ashman
CFO: Manprit Singh Randhawa
Independent Non-Executive Director: Catherine Denise Prescott
Non-Executive Chairman: Martin Braddock Hunt
Non-Executive Dir: Danielle Bekker

Contact Details

Address: The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, United Kingdom, NE4 5TF
Phone: +44 191 495 7325
Website: http://www.skinbiotherapeutics.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BF33H870

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 15.88p
Change Today -0.38p
% Change -2.31 %
52 Week High 19.50p
52 Week Low 7.25p
Volume 615,738
Shares Issued 228.44m
Market Cap £36.26m
Beta 1.22

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
72.99% below the market average72.99% below the market average72.99% below the market average72.99% below the market average72.99% below the market average
96% below the sector average96% below the sector average96% below the sector average96% below the sector average96% below the sector average
Price Trend
1.45% above the market average1.45% above the market average1.45% above the market average1.45% above the market average1.45% above the market average
51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average
Income Not Available
Growth
21.88% above the market average21.88% above the market average21.88% above the market average21.88% above the market average21.88% above the market average
11.76% above the sector average11.76% above the sector average11.76% above the sector average11.76% above the sector average11.76% above the sector average

SBTX Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
15:51 7,500 @ 15.95p
14:41 100,000 @ 15.75p
14:39 100,000 @ 15.75p
15:10 6 @ 15.50p
15:10 187 @ 16.00p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page